HELP

Cybin Inc. Common Stock

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Steven CohenPoint72
$94k19.7k shares
TrimQ1 2026
$36M
$4.80
$4.43
Ken GriffinCitadel Advisors
$4.4M915.6k shares
TrimQ1 2026
$2.8M
$4.80
$4.43
Steven CohenPoint72
$36M4.4M shares
AddQ4 2025
$29M
$8.18
$4.43
Steven CohenPoint72
$36M4.4M shares
ExitQ4 2025
$7.3M
$8.18
$4.43
Ken GriffinCitadel Advisors
$7.2M875.6k shares
AddQ4 2025
$6.1M
$8.18
$4.43
Ken GriffinCitadel Advisors
$7.2M875.6k shares
ExitQ4 2025
$1.1M
$8.18
$4.43

News

globenewswire.comHelus Pharma to Participate in the Jefferies Global Healthcare Conference in New Yorkglobenewswire.comJun 1globenewswire.comCORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Healthglobenewswire.comApr 30globenewswire.comHelus Pharma to Participate at the 29th Annual Milken Institute Global Conferenceglobenewswire.comApr 30globenewswire.comHelus Pharma Partners with TARA Mind to Advance Veteran Mental Healthglobenewswire.comApr 28globenewswire.comHelus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannanglobenewswire.comApr 23